Abstract
The metabolism of safrole (4-allyl-1,2-methylenedioxybenzene) and safrole epoxide [1,2-methylenedioxy-4-(2,3-epoxypropyl)benzene] was studied in the rat and guinea pig. After intraperitoneal administration of safrole, the major urinary metabolites identified by gas chromatography and mass spectrometry were 1,2-dihydroxy-4-allylbenzene, 1,2-methylenedioxy-4-(1-hydroxyallyl)benzene, 1,2-methylenedioxy-4-(2,3-dihydroxypropyl)benzene, 1,2-dihydroxy-4-(2,3-dihydroxypropyl)benzene, 2-hydroxy-3-(3,4-methylenedioxyphenyl)propanoic acid, and 3,4-methylenedioxybenzoylglycine. The conversion of the allyl side chain to a 2,3-dihydroxypropyl side chain probably involves safrole epoxide as an intermediate. After intraperitoneal administration of safrole epoxide, 1,2-methylenedioxy-4-(2,3-dihydroxypropyl)benzene, 1,2-dihydroxy-4-(2,3-dihydroxypropyl)benzene, 2-hydroxy-3-(3,4-methylenedioxyphenyl)propanoic acid, and 2-hydroxy-3-(3,4-dihydroxyphenyl)propanoic acid were identified in rat and guinea pig urine. A small amount of a triol [1,2-methylenedioxy-4-(1,2,3-trihydroxypropyl)benzene] was found only in rat urine. Unchanged safrole epoxide was also found in the urine of both species, indicating that the epoxide was sufficiently stable in vivo to circulate in the blood and to be excreted in urine.
Footnotes
- Received July 29, 1974.
- Copyright © 1974 by The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|